Last reviewed · How we verify

NCT03854292

Hydrosalpinx Management Before Intracytoplasmic Sperm Injection

Completed Last updated 15 July 2019
What this trial tests

trial testing Hysteroscopic tubal electrocoagulation in Hydrosalpinx in 50 participants. Completed in 31 May 2018.

Timeline
1 March 2017
Primary endpoint
31 May 2018
31 May 2018

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 March 2017
Primary completion31 May 2018
Estimated completion31 May 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 35, female only, with Hydrosalpinx. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ICSI pregnancy outcomes following hysteroscopic tubal electrocoagulation versus laparoscopic tubal disconnection for patients with hydrosalpinges

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03854292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing